EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Epithelial-Myoepithelial Carcinoma of the Parotid Gland Misdiagnosed as Rhabdomyosarcoma and Non-Hodgkin Lymphoma: A Case Report of a Diagnostic Dilemma

Gerald Ekene Ugwoke, Dickson S Okoh, Osawe A Omoregie, Anthony O Osaguona, Emmanuel Aimebelomo Ikhile

Nigerian Dental Journal · 2026

DOI: 10.61172/caa60p74 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Nigerian Dental Journal, 2026. Verfasst von Gerald Ekene Ugwoke und 4 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Epithelial-myoepithelial carcinoma (EMC) is a rare biphasic salivary gland malignancy that can pose diagnostic challenges. We describe a 52-year-old man whose recurrent right parotid and upper-neck mass was initially considered rhabdomyosarcoma and subsequently non-Hodgkin lymphoma (NHL), before reassessment favoured EMC. Case Report: After an initial biopsy suggesting rhabdomyosarcoma, the patient underwent excision at a private facility. Postoperative histopathology suggested NHL, and lymphoma-directed chemotherapy was unsuccessful. Initial immunohistochemistry (IHC) showed CD45, CD10 and pancytokeratin reactivity, producing an inconclusive interpretation. He was referred for reassessment with a recurrent right parotid, submandibular and upper-neck mass and cervical and axillary lymphadenopathy. Ultrasound demonstrated a heterogeneous mass, while magnetic resonance imaging demonstrated an extensive multinodular, multilobulated neck lesion. Cytology identified malignancy, possibly salivary adenocarcinoma. Repeat biopsy showed clear-cell myoepithelial-appearing tumour cells in nests and sheets with prominent basement-membrane material and hyalinization. IHC demonstrated pancytokeratin and vimentin positivity. The integrated morphologic and immunophenotypic findings supported a diagnosis of EMC, although the limited panel restricts definitive exclusion of mimics. The lesion was considered unresectable; six cycles of chemotherapy were administered at three-week intervals. Clinical reduction of the mass was reported, with no recurrence reported more than one year after treatment.

Conclusion

Reassessment of a recurrent salivary-region tumour after discordant diagnoses can clarify management. Morphology should be interpreted alongside a sufficiently discriminating IHC panel; limited marker positivity alone does notestablish EMC. This case illustrates the importance of diagnostic review when treatment response is unexpected. Keywords: epithelial-myoepithelial carcinoma, rhabdomyosarcoma, non-Hodgkin lymphoma, case report, histopathology, immunohistochemistry

Zitieren

APA

Ugwoke, G. E., Okoh, D. S., Omoregie, O. A., Osaguona, A. O., & Ikhile, E. A. (2026). Epithelial-Myoepithelial Carcinoma of the Parotid Gland Misdiagnosed as Rhabdomyosarcoma and Non-Hodgkin Lymphoma: A Case Report of a Diagnostic Dilemma. Nigerian Dental Journal. https://doi.org/10.61172/caa60p74

Vancouver

Ugwoke GE, Okoh DS, Omoregie OA, Osaguona AO, Ikhile EA. Epithelial-Myoepithelial Carcinoma of the Parotid Gland Misdiagnosed as Rhabdomyosarcoma and Non-Hodgkin Lymphoma: A Case Report of a Diagnostic Dilemma. Nigerian Dental Journal. 2026. doi:10.61172/caa60p74

BibTeX
@article{Ugwoke2026,
  author = {Ugwoke, Gerald Ekene and Okoh, Dickson S and Omoregie, Osawe A and Osaguona, Anthony O and Ikhile, Emmanuel Aimebelomo},
  title = {Epithelial-Myoepithelial Carcinoma of the Parotid Gland Misdiagnosed as Rhabdomyosarcoma and Non-Hodgkin Lymphoma: A Case Report of a Diagnostic Dilemma},
  journal = {Nigerian Dental Journal},
  year = {2026},
  doi = {10.61172/caa60p74}
}
Kostenlos starten →